Valuation (34%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 9.53 | 19.91 |
PEG Ratio (TTM) | -0.36 | 10.49 |
P/S Ratio (TTM) | 1.38 | 4.24 |
P/B Ratio (TTM) | 1.70 | 4.96 |
P/FCF Ratio (TTM) | -59.05 | 24.90 |
Price to 5YR AVG Earnings Ratio | -1.79 | 56.05 |
Price to 5YR AVG FCF Ratio | -0.61 | 46.36 |
Profitability (50%) |
Company | Industry |
---|---|---|
ROA (TTM) | 12.42% | -53.53% |
ROE (TTM) | 18.69% | -3.71% |
Net Profit Margin (TTM) | 9.92% | 4.09% |
ROIC 5YR AVG | -29.76% | 20.58% |
Growth (53%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 116.15% | 11.62% | 26.76% |
Revenue | 41.40% | -14.00% | 2.78% |
Net Income | 41.33% | 7.36% | 27.90% |
Cash Flow | -113.58% | -63.74% | -35.83% |
Health (35%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 3.12 | 2.21 |
Quick Ratio (TTM) | 1.40 | 1.53 |
D/E Ratio (TTM) | 0.06 | 0.61 |
Interest Coverage (TTM) | 3.94 | 3.96 |
Piotroski F-Score | 3 | 6 |
Altman Z-Score | N/A | 5.95 |
LTL to 5YR AVG FCF | -0.07 | 4.54 |
Shares Outstanding Growth 5YR AVG | 3.10% | 0.70% |